A. Varbo
Genetics · 2013–2024
A researcher in the Science corpus: 9 papers; trusts 4 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Genetics — 57 citations into it
- Endocrinology, Diabetes and Metabolism — 46 citations into it; #243 of 623 by trust here, #301 by citations
- Surgery — 38 citations into it; #441 of 1,106 by trust here, #510 by citations
- Cardiology and Cardiovascular Medicine — 27 citations into it
- Epidemiology — 15 citations into it
Whom A. Varbo trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Børge G. Nordestgaard
- Deborah Lawlor
- M. Benn
- R. Harbord
- G. Moneta
- J. Sterne
- George Davey Smith
- P. P. Toth
Who trusts A. Varbo overall
Papers from A. Varbo's perspective
Ordered by how strongly the researchers A. Varbo trusts endorse each paper. Same corpus, a different order for every researcher.
- Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. (Journal of the American Medical Association (JAMA))
- Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology (Statistics in Medicine)
- Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
- Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. (New England Journal of Medicine)
- Inflammation, Atherosclerosis and Coronary Artery Disease (Clinical Medicine Insights: Cardiology)
- A global reference for human genetic variation
- The UK10K project identifies rare variants in health and disease (Nature)
- Effects of torcetrapib in patients at high risk for coronary events. (New England Journal of Medicine)
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. (European Heart Journal)
- Food Security (ACM SIGSPATIAL International Workshop on Advances in Geographic Information Systems)
Their papers
- The UK10K project identifies rare variants in health and disease (2015) — 1,063 citations
- Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants (2024) — 676 citations
- Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults (2024) — 1,570 citations
- Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants (2021) — 2,636 citations
- Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes (2017) — 401 citations
- Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel (2015) — 384 citations
- Triglycerides and cardiovascular disease. (2014) — 1,388 citations
- Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation (2013) — 604 citations
- Remnant cholesterol as a causal risk factor for ischemic heart disease. (2013) — 1,030 citations